On Monday, the European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents pharmaceutical firms across Europe, has made a pledge to ”reduce inequalities in patient access to medicines across Europe,” the organization has announced in a press release, as reported by Endpoints News.
The proposal entails the commitment by member companies to file for market access, including pricing and reimbursement, in all EU member countries ”as soon as possible and no later than two years” post EU approval, should local authorities enable it.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Rumored GN purchase unlikely but not impossible, say analysts
A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.
EMA begins analyzing Bavarian Nordic's vaccine against monkeypox
Prior to deciding on a shared European vaccine supply purchase, the European Medicines Agency has begun analyzing the Danish firm’s smallpox vaccine against monkeypox.
Bavarian Nordic eyes European monkeypox approval for smallpox vaccine
Bavarian Nordic’s smallpox vaccine, Jynneos, hasn’t yet been approved for monkeypox in Europe, a fact that hasn’t stopped countries there from lining up to secure vaccine supplies in light of the recent outbreak.
New CFO wants to shake things up at WSA
A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.
Chinese patent expiration dates draw closer for Novo Nordisk
In coming years, Novo Nordisk will take blows in the shape of several patents terminating on the second-biggest market for the firm, a Danish media reports.
Director for innovative pre-clinical testing unit 
Communications Consultant 
Laboratory technician for process development and clinical manufacturing 
Senior Project Manager (GMP - Life Science) 
Strategic Procurement Manager, Direct Spend (Category Manager) 
Key Account Manager, Europe and Asia 
Clinical Trial Manager for development of in vitro diagnostics 
Client Talent Acquisition Specialist 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Account Manager 
Analytical Senior Scientist 
Biostatistician 
Production Director 
Nordic Medical Affairs Manager 
System Sales Development Consultant - Investment Projects, Merck Millipore 
IRT Manager, Clinical Drug Supply